Timothy McAdam
About Timothy McAdam
Timothy McAdam, age 56, is the independent Chairman of Alarm.com’s Board (Chair since April 2015; director since July 2012). He is a General Partner at Technology Crossover Ventures (TCV) with a technology investing career dating back to 1991, and holds a B.A. in Classics from Dartmouth College and an M.B.A. from Stanford Graduate School of Business . The Board has affirmatively determined McAdam is independent under Nasdaq rules, and Alarm.com maintains a leadership structure with an independent Chair to enhance objective oversight of management .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Technology Crossover Ventures (TCV) | General Partner | 1991–present | Technology investor; builds technology companies |
External Roles
| Organization | Role | Company Type |
|---|---|---|
| Vectra | Director | Cybersecurity company |
| Oversight | Director | Application software company |
| Perceptyx | Director | Cloud-based software for employee engagement |
| Aviatrix | Director | Infrastructure cloud software company |
| BenchSci | Director | Cloud-based AI software serving pharmaceutical vertical |
| Passport Global | Director | Shipping and logistics software business |
| Roofr | Director | Vertical SaaS focused on roofing |
No public-company directorships or disclosed interlocks with ALRM suppliers/customers were identified in the proxy .
Board Governance
- Independence: All directors except the CEO (Stephen Trundle) are independent under Nasdaq standards; McAdam is independent .
- Board leadership: Independent Chair (McAdam) with authority to set agendas, preside over meetings (including independent director sessions), and coordinate risk oversight .
- Attendance: The Board met four times in 2024; each director attended ≥75% of Board and applicable committee meetings; all directors attended the 2024 Annual Meeting in person .
- Committees (2024 meetings shown):
- Compensation Committee: McAdam member; 5 meetings .
- Nominating & Corporate Governance Committee: McAdam Chair; 4 meetings .
- Audit Committee: McAdam not a member; 4 meetings .
- Nominating & Corporate Governance scope: Director selection and evaluation, committee structure, Board assessment, ESG oversight, and succession planning; all members are independent .
| Committee | McAdam Role | 2024 Meetings |
|---|---|---|
| Compensation | Member | 5 |
| Nominating & Corporate Governance | Chair | 4 |
| Audit | Not a member | 4 |
Fixed Compensation
- Policy: Non-employee directors receive cash and equity; Board updated director compensation in Sept 2023 effective Jan 1, 2024, with Compensia advising and benchmarking against ALRM’s executive compensation peer group .
- Cash components (policy):
- Board service retainer: $40,000 for directors; $50,000 for the Chairman (McAdam) .
- Committee member retainers: Audit $15,000; Compensation $7,500 (increased from $5,000); Nominating & Corporate Governance $7,500 (increased from $5,000) .
- Committee chair retainers: Audit $20,000; Compensation $15,000; Nominating & Corporate Governance $10,000 .
- Additional Chair of the Board retainer increased from $10,000 to $25,000 (effective Jan 1, 2024) .
| Year | Fees Earned or Paid in Cash ($) | Source |
|---|---|---|
| 2024 | 78,125 | Director compensation table |
Cash retainer is paid quarterly in arrears; pro-rating applies for mid-quarter appointments .
Performance Compensation
- Equity awards: ALRM grants annual RSUs to non-employee directors; grant date fair value targeted at $145,000, converted into shares using the closing price on date of grant; vest in full immediately before the next annual meeting if continuous service is maintained . RSUs accelerate to fully vested immediately prior to closing of a change in control if the director remains in service until that time .
- 2024 grant value (reported fair value): $144,991 for McAdam (ASC 718) .
- Equity plan guardrail: Under the 2025 Equity Incentive Plan, non-employee director total annual compensation (cash fees + equity grant date fair value) cannot exceed $325,000, excluding dividend equivalents from prior-year grants .
| Year | Stock Awards (Grant-Date Fair Value, $) | Vesting | Change-in-Control Treatment |
|---|---|---|---|
| 2024 | 144,991 | Full vesting immediately prior to next annual meeting if still serving | Full acceleration immediately prior to closing if in continuous service |
Company incentive metrics context (applies to NEOs, not directors): SaaS & license revenue and Adjusted EBITDA are the most important financial performance measures linking pay to performance for 2024 . Directors are not subject to performance-based equity at ALRM; awards are time-based RSUs .
Other Directorships & Interlocks
| Type | Detail |
|---|---|
| Additional roles | McAdam serves on the boards of Vectra, Oversight, Perceptyx, Aviatrix, BenchSci, Passport Global, and Roofr |
| Interlocks/conflicts | No related person transactions >$120,000 involving directors were disclosed for period since Jan 1, 2024 (other than standard compensation) |
| Independence confirmation | Committee members (including McAdam on Compensation; McAdam as Chair of Nominating & Corporate Governance) meet Nasdaq independence standards |
Expertise & Qualifications
- Technology investor and company builder with decades in growth equity/venture capital; specific expertise in technology, leadership, and M&A, as noted by the Board in supporting his nomination .
- Board believes his experience qualifies him for continued Board service .
Equity Ownership
- Beneficial ownership as of March 31, 2025: 102,802 shares; percent reported as “*” (<1%) based on 49,679,679 shares outstanding .
- Outstanding director equity positions (as of Dec 31, 2024): Stock awards 2,304; options: none for McAdam .
- Ownership guidelines: Non-employee directors must hold the lesser of 3x their annual cash retainer or 2,500 shares; unvested RSUs and unexercised options do not count. As of March 31, 2025, all non-employee directors were compliant except Ms. Harper (appointed May 16, 2024 and within phase-in window) .
| Metric | Amount | Date/Notes |
|---|---|---|
| Shares beneficially owned | 102,802 | As of Mar 31, 2025 |
| % of shares outstanding | * | Company table denotes under 1% |
| Outstanding stock awards (#) | 2,304 | As of Dec 31, 2024 |
| Outstanding options (#) | 0 | As of Dec 31, 2024 |
| Ownership guideline | Lesser of 3x cash retainer or 2,500 shares | Unvested RSUs/options excluded |
| Compliance status | Compliant | As of Mar 31, 2025 |
Insider Trades (Section 16)
| Date | Type | Shares | Price | Post-Transaction Holdings | Source |
|---|---|---|---|---|---|
| Jun 6, 2024 | Acquisition (Non-Open Market; stock award grant) | 2,510 | 0.00 | 107,616 | |
| Jun 6, 2025 | Form 4 filing (details available in SEC accession) | — | — | — |
Additional Section 16 filings are listed on ALRM’s IR site; the specific Nov 14, 2025 Form 4 is available for download (details beyond the scope of McAdam’s June filings above) .
Governance Assessment
- Board effectiveness: McAdam’s independent Chair role and committee leadership (Nominating & Corporate Governance Chair; Compensation member) strengthen governance oversight, agenda control, and succession planning/ESG oversight .
- Alignment and incentives: Director equity is time-based RSUs with annual grant value near $145k and change-in-control acceleration—typical market practice; equity plus cash remains below the $325k cap under the 2025 plan, limiting pay inflation risk .
- Independence and conflicts: No related-party transactions >$120k involving directors were disclosed for 2024+, and Board independence standards are met across committees .
- Attendance and engagement: ≥75% attendance for all directors across Board/committee meetings; McAdam attended the Annual Meeting with all directors .
- RED FLAGS:
- Change-in-control acceleration for director RSUs can be seen as entrenching, but it is broadly standard; oversight remains with independent committees .
- A tax gross-up was disclosed for a different director’s reimbursed equipment expense (not McAdam), signaling attentiveness for perquisite governance; no similar gross-ups disclosed for McAdam .
Overall signal: Independent leadership, strong committee engagement, compliance with ownership guidelines, and absence of related-party exposure support investor confidence in McAdam’s governance posture .